Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,838.50
-32.50 (-1.74%)
At close: Nov 12, 2026
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 18.64 billion as of November 12, 2026. It is the 20,445th most valuable company in the world and the 1,293rd biggest in India. Its market cap has increased by 10.25% in one year.
Market Cap
18.64B
Enterprise Value
18.87B
Revenue
4.10B
Global Rank
Country Rank
#1,293 India
PE Ratio
41.49
ChartMarket Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 18.64B, an increase of 1,934.61%. That is a compound annual growth rate of 39.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 18.64B | 19.18% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |
| Ind-Swift Laboratories | 30.35B |
| Sakar Healthcare | 22.89B |
| Indoco Remedies | 20.25B |
| Windlas Biotech | 20.10B |
| Jagsonpal Pharmaceuticals | 14.36B |
| Anlon Healthcare | 14.31B |